The evolving culture of medical cannabis in Canada for the management of chronic pain

Although used therapeutically for millennia, cannabis has been a prohibited substance worldwide for most of the 20th Century. With revision of prohibitive regulations in many jurisdictions during the past 2 decades, cannabis is increasingly available to patients as a potential treatment option for v...

Full description

Bibliographic Details
Main Authors: H. Clarke, M. Fitzcharles
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1153584/full
_version_ 1797850954743152640
author H. Clarke
H. Clarke
H. Clarke
M. Fitzcharles
M. Fitzcharles
author_facet H. Clarke
H. Clarke
H. Clarke
M. Fitzcharles
M. Fitzcharles
author_sort H. Clarke
collection DOAJ
description Although used therapeutically for millennia, cannabis has been a prohibited substance worldwide for most of the 20th Century. With revision of prohibitive regulations in many jurisdictions during the past 2 decades, cannabis is increasingly available to patients as a potential treatment option for various symptoms. Pain relief, sleep promotion and alleviation of distress, depression and anxiety are the most common reasons for cannabis use. Canada has been at the forefront of medical cannabis (MC) legislation revisions to enable and facilitate access for therapeutic use. Although initially viewed with caution and stigma, attitudes to cannabis in general have changed. Medical cannabis is identified as the herbal plant product sourced from a grower/producer and is not at present a regulated pharmaceutical product. Medical cannabis use is currently prevalent in Canada but has bypassed the rigorous study required for usual drug approval. Although uptake has been enthusiastic by patients, the medical community has voiced cautions and concerns. Access to medical cannabis is fairly easy once an approval document is obtained from a healthcare professional, but without obligation for medical or pharmacy oversight. The greatest concern is a dearth of sound clinical evidence for effects and harms. Emerging concerns include prevalent patient self-management with information based on personal research, an abundance of on-line information which may not always be accurate, the emergence of designated “cannabis clinics,” potential risks to society due to accidents, and high cost of the legal medical product leading to access via the recreational market. With cannabis now entrenched in Canadian healthcare, physicians must be sufficiently knowledgeable to provide guidance that is evidence-based and will ensure personal and societal harm reduction. Examination of the changing culture of medical cannabis in Canada will provide insight for countries that may be anticipating similar revisions of cannabis regulations to allow cannabis access for their patient population and learn from the issues created by recreational legalization.
first_indexed 2024-04-09T19:08:54Z
format Article
id doaj.art-2168fab6bbf34251821bf49b2cb30df9
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-09T19:08:54Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-2168fab6bbf34251821bf49b2cb30df92023-04-07T04:24:29ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-04-011410.3389/fphar.2023.11535841153584The evolving culture of medical cannabis in Canada for the management of chronic painH. Clarke0H. Clarke1H. Clarke2M. Fitzcharles3M. Fitzcharles4Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, CanadaDepartment of Anesthesia and Pain Management Pain Research Unit, Toronto General Hospital, Toronto, ON, CanadaTransitional Pain Service, Toronto General Hospital, Toronto, ON, CanadaDepartment of Rheumatology, McGill University, Montreal, QC, CanadaAlan Edwards Pain Management Unit, McGill University, Montreal, QC, CanadaAlthough used therapeutically for millennia, cannabis has been a prohibited substance worldwide for most of the 20th Century. With revision of prohibitive regulations in many jurisdictions during the past 2 decades, cannabis is increasingly available to patients as a potential treatment option for various symptoms. Pain relief, sleep promotion and alleviation of distress, depression and anxiety are the most common reasons for cannabis use. Canada has been at the forefront of medical cannabis (MC) legislation revisions to enable and facilitate access for therapeutic use. Although initially viewed with caution and stigma, attitudes to cannabis in general have changed. Medical cannabis is identified as the herbal plant product sourced from a grower/producer and is not at present a regulated pharmaceutical product. Medical cannabis use is currently prevalent in Canada but has bypassed the rigorous study required for usual drug approval. Although uptake has been enthusiastic by patients, the medical community has voiced cautions and concerns. Access to medical cannabis is fairly easy once an approval document is obtained from a healthcare professional, but without obligation for medical or pharmacy oversight. The greatest concern is a dearth of sound clinical evidence for effects and harms. Emerging concerns include prevalent patient self-management with information based on personal research, an abundance of on-line information which may not always be accurate, the emergence of designated “cannabis clinics,” potential risks to society due to accidents, and high cost of the legal medical product leading to access via the recreational market. With cannabis now entrenched in Canadian healthcare, physicians must be sufficiently knowledgeable to provide guidance that is evidence-based and will ensure personal and societal harm reduction. Examination of the changing culture of medical cannabis in Canada will provide insight for countries that may be anticipating similar revisions of cannabis regulations to allow cannabis access for their patient population and learn from the issues created by recreational legalization.https://www.frontiersin.org/articles/10.3389/fphar.2023.1153584/fullmedicalcannabislegalizationchronicpain
spellingShingle H. Clarke
H. Clarke
H. Clarke
M. Fitzcharles
M. Fitzcharles
The evolving culture of medical cannabis in Canada for the management of chronic pain
Frontiers in Pharmacology
medical
cannabis
legalization
chronic
pain
title The evolving culture of medical cannabis in Canada for the management of chronic pain
title_full The evolving culture of medical cannabis in Canada for the management of chronic pain
title_fullStr The evolving culture of medical cannabis in Canada for the management of chronic pain
title_full_unstemmed The evolving culture of medical cannabis in Canada for the management of chronic pain
title_short The evolving culture of medical cannabis in Canada for the management of chronic pain
title_sort evolving culture of medical cannabis in canada for the management of chronic pain
topic medical
cannabis
legalization
chronic
pain
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1153584/full
work_keys_str_mv AT hclarke theevolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT hclarke theevolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT hclarke theevolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT mfitzcharles theevolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT mfitzcharles theevolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT hclarke evolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT hclarke evolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT hclarke evolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT mfitzcharles evolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain
AT mfitzcharles evolvingcultureofmedicalcannabisincanadaforthemanagementofchronicpain